My Dashboard FDA Guidance FDA Guidance Library Search every FDA guidance document for drugs, devices and biologics. Each result links to the official FDA source.
Last Updated Nov 14, 2026 HintSearch for a specific guidance document by title, description or FDA Media ID using the search box at the top.
Need the Form, Not the Guidance? eSTAR, Q-Sub and Form FDA 3938 live in Global Templates. Open Global Templates No filters applied
1,845 Guidance Documents
Final IVDs (In Vitro Diagnostic Devices)
Nov 10, 2026 Center for Devices and Radiological Health; Office of Product Evaluation and Quality; Office of In Vitro Diagnostics and Radiological Health 641.15 KBFinal Hepatitis B Blood Products Testing
Recommendations for Testing Blood Donations for Hepatitis B Surface Antigen: Draft Guidance for Industry Nov 3, 2026 Center for Biologics Evaluation and Research 310.58 KBFinal Gene Therapy
Nov 2, 2026 Center for Biologics Evaluation and Research 478.7 KBFinal ICH-Efficacy ICH-Safety
Oct 30, 2026 Center for Drug Evaluation and Research 518.63 KBDraft, Open for Comment Combination Products Pediatric Product Development
Oct 29, 2026 Office of the Commissioner; Office of Clinical Policy and Programs; Office of Combination Products; Center for Biologics Evaluation and Research; Center for Devices and Radiological Health; Center for Drug Evaluation and Research 613.1 KB Comment Period Closes Jan 28, 2027Draft, Open for Comment Electronic Submissions
Oct 28, 2026 Center for Devices and Radiological Health 451.99 KB Comment Period Closes Dec 28, 2026Draft, Open for Comment Gene Therapy
Oct 27, 2026 Center for Biologics Evaluation and Research 384.05 KB Comment Period Closes Nov 27, 2026Final Labeling
Oct 20, 2026 Center for Drug Evaluation and Research; Center for Biologics Evaluation and Research; Center for Devices and Radiological Health; Oncology Center of Excellence 404.43 KBFinal Technical Specifications
Oct 20, 2026 Center for Drug Evaluation and Research 710.97 KBFinal Generic Drugs Good Clinical Practice (GCP) Safety - Issues, Errors, and Problems
Oct 19, 2026 Center for Drug Evaluation and Research; Center for Biologics Evaluation and Research 227.63 KBFinal Blood Coronavirus Blood Products
Oct 14, 2026 Center for Biologics Evaluation and Research 285.14 KBFinal Blood Blood Products
Oct 14, 2026 Center for Biologics Evaluation and Research 245.08 KBFinal Current Good Manufacturing Practice (CGMP)
Oct 9, 2026 Center for Drug Evaluation and Research; Center for Biologics Evaluation and Research 282.51 KBFinal Biosimilars
Final guidance with questions and answers on biosimilar development and the Biologics Price Competition and Innovation Act. Oct 9, 2026 Center for Drug Evaluation and Research 335.66 KBFinal
Oct 8, 2026 Center for Drug Evaluation and Research 1.33 MBFinal ICH-Efficacy
Oct 1, 2026 Center for Drug Evaluation and Research 343.52 KBDraft, Open for Comment Premarket
Sep 25, 2026 Center for Devices and Radiological Health 819.89 KB Comment Period Closes Nov 24, 2026Draft, Open for Comment Electronic Submissions
Sep 18, 2026 Center for Devices and Radiological Health 451.92 KBFinal Blood Blood Products
Sep 16, 2026 Center for Biologics Evaluation and Research 317.34 KBFinal Compounding
Sep 8, 2026 Center for Drug Evaluation and Research 391.23 KBFinal Premarket 510(k) Dental
Sep 2, 2026 Center for Devices and Radiological Health 386.5 KBDraft, Open for Comment Clinical - Pharmacology
Sep 2, 2026 Center for Drug Evaluation and Research 315.27 KB Comment Period Closes Dec 1, 2026Final Premarket 510(k) Dental
Sep 2, 2026 Center for Devices and Radiological Health 427.29 KBFinal Drug Competition Action Plan Generic Drugs
Aug 21, 2026 Center for Drug Evaluation and Research 362.08 KBDraft, Open for Comment Gene Therapy
Aug 19, 2026 Center for Biologics Evaluation and Research 375.16 KB Comment Period Closes Nov 18, 2026